Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,874 shares at $288.68 ($827K) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Open-market sale of $827k VRTX by SVP & Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $289.12 | 502 | $145K | 17.5% |
| 2 | $287.25 | 982 | $282K | 34.1% |
| 3 | $287.25 | 982 | $282K | 34.1% |
| 4 | $288.68 | 183 | $53K | 6.4% |
| 5 | $288.68 | 183 | $53K | 6.4% |
| 6 | $289.63 | 42 |
| $12K |
| 1.5% |
| Total | $287.79 avg | 2,874 | $827K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |